GeneDx Holdings Corp. Stock Split Ratio
GeneDx Holdings Corp. (WGS) reported Stock Split Ratio of 3.00% for the 12-month period ending 2023-12-31, per its 10-K filed 2024-02-23.
Discontinued › Notes › Stockholders' Equity Note
us-gaap:StockholdersEquityNoteStockSplitConversionRatio1 · last filed 2024-02-23
- GeneDx Holdings Corp. stockholders' equity note, stock split, conversion ratio for the quarter ending 2023-03-31 was 3.00%.
- GeneDx Holdings Corp. stockholders' equity note, stock split, conversion ratio for fiscal 2023 was 3.00%.
| Period end | Stockholders' Equity Note, Stock Split, Conversion Ratio | Stockholders' Equity Note, Stock Split, Conversion Ratio 3 month | Stockholders' Equity Note, Stock Split, Conversion Ratio 6 month | Stockholders' Equity Note, Stock Split, Conversion Ratio 9 month | Stockholders' Equity Note, Stock Split, Conversion Ratio 12 month |
|---|---|---|---|---|---|
| 2023-12-31 | 3.00% 10-K · filed 2024-02-23 | ||||
| 2023-09-30 | 3.00% 10-Q · filed 2023-11-03 | ||||
| 2023-06-30 | 3.00% 10-Q · filed 2023-08-08 | ||||
| 2023-05-04 | 3.00% 10-K · filed 2024-02-23 | ||||
| 2023-03-31 | 3.00% 10-Q · filed 2023-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B |